Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone

NCT00522392 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

48

Enrollment

NIH

Sponsor class

Stopped Slow accrual

Conditions

Stage I Multiple Myeloma
Stage II Multiple Myeloma
Stage III Multiple Myeloma

Interventions

DRUG: bortezomib
DRUG: lenalidomide
DRUG: dexamethasone

Sponsor

National Cancer Institute (NCI)